June 13, 2016 – Before and after the 2016 elections, Washington health policy will remain fixed on improving the path to drug innovation, achieving legislative reform to secure that path, and responding to concerns about drug pricing, according to Prevision Policy’s Kate Rawson, who spoke at the recent Coalition for Healthcare Communication Rising Leaders Conference […]
Read more